{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:34:36Z","timestamp":1788554076254,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The immunosuppressant mycophenolate mofetil (MMF) is used off-label in patients with systemic lupus erythematosus (SLE) although the optimum dosing regimen is not well established. This study evaluated the use of volumetric absorptive microsampling (VAMS) for capillary whole blood collected by finger-prick, combined with tandem mass spectrometry and limited timepoint sampling to determine concentrations of mycophenolic acid (MPA) and its glucuronide conjugate, MPA-7-O-glucuronide (MPAG) in SLE patients. This approach permitted pharmacokinetically guided optimized dosing of MPA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Blood was collected by finger-prick and venipuncture from patients (n = 10) at trough, 30, and 120\u2005min postdosing with MMF. MPA\/MPAG concentrations were assayed from dried VAMS devices by stable-isotope dilution LC-MS-MS and compared to MPA\/MPAG concentrations measured in plasma by high performance liquid chromatography after adjusting for hematocrit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was no significant difference between MPA concentrations from VAMS-collected dried capillary blood hematocrit-adjusted and those for plasma. The area under the concentration-time curve (AUC) estimated from plasma equivalent concentrations converted from capillary VAMS results correlated well with the AUC estimated from plasma concentrations (R2 = 0.97).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The plasma pharmacokinetics of MMF metabolites can be reliably estimated from concentrations in capillary blood using VAMS devices and only 3 timed collections. Sampling whole blood by finger-prick, a less invasive approach for patients, coupled with the specificity of LC-MS\/MS can be accurately used as an alternative to plasma sampling to establish the optimal dosing regimen of MMF for patients with SLE based on dried blood samples.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfaf022","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T20:23:02Z","timestamp":1741378982000},"page":"806-819","source":"Crossref","is-referenced-by-count":6,"title":["Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis Patients"],"prefix":"10.1093","volume":"10","author":[{"given":"Junfang","family":"Zhao","sequence":"first","affiliation":[{"name":"Division of Pathology & Laboratory Medicine, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-3294","authenticated-orcid":false,"given":"Xueheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Pathology & Laboratory Medicine, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Translational and Clinical Pharmacology, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Irie","sequence":"additional","affiliation":[{"name":"Division of Translational and Clinical Pharmacology, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Devarajan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]},{"name":"Division of Nephrology & Hypertension, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-2987","authenticated-orcid":false,"given":"Hermine I","family":"Brunner","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D R","family":"Setchell","sequence":"additional","affiliation":[{"name":"Division of Pathology & Laboratory Medicine, Cincinnati Children\u2019s Hospital Medical Center , Cincinnati, OH ,","place":["United States"]},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"2025070109064202600_jfaf022-B1","doi-asserted-by":"crossref","first-page":"e001093","DOI":"10.1136\/lupus-2023-001093","article-title":"Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis","volume":"11","author":"Wuttiputhanun","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2025070109064202600_jfaf022-B2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.semarthrit.2010.05.007","article-title":"Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus","volume":"40","author":"Sagcal-Gironella","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2025070109064202600_jfaf022-B3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"2025070109064202600_jfaf022-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmsacl.2023.11.004","article-title":"Use of volumetric absorptive microsampling and parallel reaction monitoring mass spectrometry for tacrolimus blood trough measurements at home in pediatric heart transplant patients","volume":"31","author":"Zhao","year":"2024","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"2025070109064202600_jfaf022-B5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.acc.2016.04.001","article-title":"Therapeutic drug monitoring of mycophenolic acid","volume":"76","author":"Dasgupta","year":"2016","journal-title":"Adv Clin Chem"},{"key":"2025070109064202600_jfaf022-B6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2025070109064202600_jfaf022-B7","doi-asserted-by":"crossref","first-page":"113491","DOI":"10.1016\/j.jpba.2020.113491","article-title":"Hematocrit prediction in volumetric absorptive microsamples","volume":"190","author":"Capiau","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"2025070109064202600_jfaf022-B8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s43440-023-00509-w","article-title":"Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application","volume":"75","author":"Kocur","year":"2023","journal-title":"Pharmacol Rep"},{"key":"2025070109064202600_jfaf022-B9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bcp.12392","article-title":"Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring","volume":"78","author":"Woillard","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"2025070109064202600_jfaf022-B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2011.010","article-title":"Comparison of methods: passing and Bablok regression","volume":"21","author":"Bilic-Zulle","year":"2011","journal-title":"Biochem Med (Zagreb)"},{"key":"2025070109064202600_jfaf022-B11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"2025070109064202600_jfaf022-B12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit"},{"key":"2025070109064202600_jfaf022-B13","doi-asserted-by":"crossref","first-page":"e3976","DOI":"10.1002\/bmc.3976","article-title":"Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method","volume":"31","author":"Luszczynska","year":"2017","journal-title":"Biomed Chromatogr"},{"key":"2025070109064202600_jfaf022-B14","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/bcp.15433","article-title":"Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients","volume":"88","author":"Zwart","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025070109064202600_jfaf022-B15","doi-asserted-by":"crossref","first-page":"113422","DOI":"10.1016\/j.jpba.2020.113422","article-title":"Volumetric absorptive microsampling (VAMS) for assaying immunosuppressants from venous whole blood by LC-MS\/MS using a novel atmospheric pressure ionization probe (UniSpray)","volume":"189","author":"Paniagua-Gonzalez","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"2025070109064202600_jfaf022-B16","doi-asserted-by":"crossref","first-page":"114443","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonzalez","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"2025070109064202600_jfaf022-B17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/RHU.0000000000000357","article-title":"Use of glucuronidated mycophenolic acid levels for therapeutic monitoring in pediatric lupus nephritis patients","volume":"22","author":"Hui-Yuen","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"2025070109064202600_jfaf022-B18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/bmc.3736","article-title":"Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS\/MS assay","volume":"30","author":"Zhang","year":"2016","journal-title":"Biomed Chromatogr"},{"key":"2025070109064202600_jfaf022-B19","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.3748\/wjg.v20.i31.10715","article-title":"Clinical mycophenolic acid monitoring in liver transplant recipients","volume":"20","author":"Chen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025070109064202600_jfaf022-B20","doi-asserted-by":"crossref","first-page":"113102","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"2025070109064202600_jfaf022-B21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"key":"2025070109064202600_jfaf022-B22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"2025070109064202600_jfaf022-B23","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem"},{"key":"2025070109064202600_jfaf022-B24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0969141315593571","article-title":"Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit","volume":"23","author":"Lawson","year":"2016","journal-title":"J Med Screen"},{"key":"2025070109064202600_jfaf022-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FTD.0000000000001083","article-title":"Applications of volumetric absorptive microsampling technique: a systematic critical review","volume":"45","author":"Dodeja","year":"2023","journal-title":"Ther Drug Monit"},{"key":"2025070109064202600_jfaf022-B26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/ijms24010681","article-title":"Volumetric absorptive microsampling in therapeutic drug monitoring of immunosuppressive drugs-from sampling and analytical issues to clinical application","volume":"24","author":"Kocur","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025070109064202600_jfaf022-B27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transplant"},{"key":"2025070109064202600_jfaf022-B28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"2025070109064202600_jfaf022-B29","first-page":"563","article-title":"Efficacy and safety of pharmacokinetically-driven dosing of mycophenolate mofetil for the treatment of pediatric proliferative lupus nephritis-a double-blind placebo controlled clinical trial (the pediatric lupus nephritis mycophenolate mofetil study)","volume":"14","author":"Sagcal-Gironella","year":"2024","journal-title":"J Clin Trials"},{"key":"2025070109064202600_jfaf022-B30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00003088-199834010-00003","article-title":"Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new \u2018multiple model\u2019 dosage design, Bayesian feedback and individualised target goals","volume":"34","author":"Jelliffe","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2025070109064202600_jfaf022-B31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/0091270008321789","article-title":"Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization","volume":"48","author":"Neely","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"2025070109064202600_jfaf022-B32","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/bcp.14426","article-title":"Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care","volume":"88","author":"Mizuno","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025070109064202600_jfaf022-B33","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.ejps.2017.05.037","article-title":"Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies","volume":"109S","author":"Mizuno","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"2025070109064202600_jfaf022-B34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FTD.0000000000001045","article-title":"Model-informed estimation of acutely decreased tacrolimus clearance and subsequent dose individualization in a pediatric renal transplant patient with posterior reversible encephalopathy syndrome","volume":"45","author":"Miyagawa","year":"2023","journal-title":"Ther Drug Monit"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/4\/806\/62711077\/jfaf022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/4\/806\/62711077\/jfaf022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:06:58Z","timestamp":1751375218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/10\/4\/806\/8093440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,26]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaf022","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,26]]}}}